Dementia for people with Parkinson’s disease may occur less often, and when it does occur, ... Alzheimer’s disease pathology and vascular disease,” explained Weintraub. ...

Half as many diagnosed with depression, a delayed manifestation of Parkinson's, a reduced risk of developing vascular dementia -- but not Alzheimer's. These connections were discovered by ...

The study, carried out by experts from the University of Nottingham, found that there was nearly a 50% increased risk of ...

NHS figures suggest that over 944,000 people in the UK currently have dementia, including one in every 11 over 65 years old ...

Please provide your email address to receive an email when new articles are posted on . SGLT2 inhibitor use may reduce the risk for Alzheimer’s disease, Parkinson’s disease and vascular ...

People who have had a heart attack are at increased risk of stroke and vascular dementia; however, a new study found they may be less likely to develop Parkinson's disease. A large, nationwide ...

The incidence rate for people taking the SGLT2 drugs who developed vascular dementia was 10.6 cases per 10,000, compared with 18.7 for those taking the other drugs.

Because Alzheimer’s is just one of several diseases that cause dementia, the key distinction lies in their scope.

Tremors and 'spontaneous Parkinsonism' often linked to one dementia type Lewy Body dementia is thought to be the third-most common form of dementia, ranking after Alzheimer's and vascular dementia.

"You have frontotemporal dementia, you have Lewy Body dementia, the Korsakoff's dementia. So, there are lots of different ...

SGLT2 inhibitors lowered dementia, Parkinson’s risk by 22% For this study, the researchers accessed data from 358,862 participants with type 2 diabetes and followed them for an average of 9.6 years.